임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 해당없음모집 중· Shared Decision-MakingEmpowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care
협력: 길리어드
- 4상모집 중· HIV -1 InfectionREINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
협력: 길리어드
- 2상모집 중· Small Cell Lung Cancer ( SCLC )Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
협력: 길리어드
- 해당없음모집 중· Breast Cancer MetastaticDecision Support Tool for Patients With Advanced Breast Cancer
협력: 길리어드
- 3상모집 중· Relapsed or Refractory Large B-cell LymphomaStudy Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
협력: 길리어드
- 2상모집 중· Advanced Microsatellite Stable Colorectal CancerStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
리드: 길리어드
- 단계 미표기모집 중· Chronic Hepatitis bAdaptability of an Undetectable = Untransmissible Model for HBV
협력: 길리어드
- 1상모집 중· Chronic Inflammatory Demyelinating PolyneuropathyA Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
협력: 길리어드
- 해당없음모집 중· HIV Pre-exposure ProphylaxisHIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study
협력: 길리어드
- 단계 미표기모집 중· HIV InfectionsImplementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
리드: 길리어드
- 4상모집 중· HIV PreventionEnhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
협력: 길리어드
- 2상모집 중· Hematopoietic and Lymphatic System NeoplasmRemdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
협력: 길리어드
- 단계 미표기모집 중· Breast CancerNavigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
협력: 길리어드
- 단계 미표기모집 중· HER2-negative Breast CancerProspective Registry of ADC as First- and Second-line Treatment for Breast Cancer
협력: 길리어드
- 단계 미표기모집 중· Fungal DiseaseA Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis
협력: 길리어드
- 4상모집 중· HIV - Human Immunodeficiency VirusHIV Prevention With PrEP Among People on Opioid Replacement Therapy
협력: 길리어드
- 1/2상모집 중· Chronic Hepatitis DeltaStudy of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
리드: 길리어드
- 2상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
협력: 길리어드
- 1/2상모집 중· Triple Negative Breast CancerA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
리드: 길리어드
- 2상모집 중· Salivary Gland CancerSacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
협력: 길리어드
- 3상모집 중· Extensive Stage Small Cell Lung Cancer (ES-SCLC)Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
리드: 길리어드
- 해당없음모집 중· Vulnerable PopulationEvaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women
협력: 길리어드
- 2상모집 중· Locally Advanced Gastric AdenocarcinomaZimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
협력: 길리어드
- 3상모집 중· Disseminated Histoplasma Capsulatum InfectionEfficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
협력: 길리어드
- 1상모집 중· NeoplasmA Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
협력: 길리어드
- 1상모집 중· Gastrointestinal CancerSacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
협력: 길리어드
- 2상모집 중· Urothelial CarcinomaAdjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
협력: 길리어드
- 단계 미표기모집 중· HIV InfectionsVariation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
협력: 길리어드
- 3상모집 중· Triple Negative Breast CancerNeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
협력: 길리어드, 머크(MSD)
- 2상모집 중· Esophageal Squamous Cell CarcinomaSacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
협력: 길리어드
- 1상모집 중· Advanced Solid TumorsStudy of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
리드: 길리어드
- 1상모집 중· Localized Muscle Invasive Bladder Urothelial CarcinomaAdaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
협력: 길리어드
- 1상모집 중· Advanced Solid TumorsStudy of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
리드: 길리어드
- 2상모집 중· Ulcerative ColitisStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 길리어드
- 3상모집 중· Triple Negative Breast CancerSafety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
협력: 길리어드
- 3상모집 중· Primary Biliary CholangitisSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
리드: 길리어드
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.